Aetion
Michelle Skornicki is an accomplished professional in health economics and outcomes research with extensive experience in healthcare data analytics and policy analysis. Currently serving as Senior Director of Science at Aetion since May 2018, Michelle has advanced from Senior Scientist to Director of Science, playing a key role in transforming real-world data into credible evidence using the Aetion Evidence Platform®. Prior experience includes positions at Precision Health Economics, where Michelle managed HEOR projects and developed strategies for outcomes evaluation, and roles at Organogenesis, i3Innovus/OptumInsight, MAVERIC, and Shriners Burn Hospital/Boston University, contributing to significant health research initiatives and policy development. Michelle holds an MPH in Epidemiology and Biostatistics from Boston University School of Public Health and a Bachelor's Degree in Mathematics from Hamilton College.
This person is not in the org chart
This person is not in any teams
Aetion
9 followers
Aetion is a health care technology company that delivers real-world evidence for life sciences, payers, providers, and regulatory agencies. The Aetion Evidence Platform analyzes data from the real world to produce transparent, rapid, and scientifically validated answers on treatments, costs, and outcomes. Founded by Harvard Medical School faculty members with decades of experience in epidemiology and health outcomes research, Aetion informs health care’s most critical decisions — what works best, for whom, and when — to guide treatment development, commercialization, and payment innovation into health care’s modern era.